Branched-chain amino acid needs in children with mild-to-moderate chronic cholestatic liver disease.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of NutriLife

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/JN/136.1.133PMID 16365072
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Branched-chain amino acid supplementation in patients with liver diseases.

  2005cited by this paper
• Effects of liver failure on branched-chain alpha-keto acid dehydrogenase complex in rat liver and muscle: comparison between acute and chronic liver failure.

  2004cited by this paper
• The use of MIXED models in the analysis of animal experiments with repeated measures data

  2004cited by this paper
• Distribution of fasting plasma insulin, free fatty acids, and glucose concentrations and of homeostasis model assessment of insulin resistance in a representative sample of Quebec children and adolescents.

  2003cited by this paper
• Serum insulinlike growth factor-I in biliary atresia.

  2003cited by this paper
• Valine may be the first limiting branched-chain amino acid in egg protein in men.

  2003cited by this paper
• Branched-chain amino acid requirements in school-aged children determined by indicator amino acid oxidation (IAAO).

  2003cited by this paper
• The total branched-chain amino acid requirement in young healthy adult men determined by indicator amino acid oxidation by use of L-[1-13C]phenylalanine.

  2003cited by this paper
• Body Composition and Components of Energy Expenditure in Children With End- Stage Liver Disease

  2003cited by this paper
• Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial.

  2003cited by this paper
• Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids.

  2002cited by this paper
• Phenylalanine requirement in children with classical PKU determined by indicator amino acid oxidation.

  2002cited by this paper
• Tyrosine requirements in children with classical PKU determined by indicator amino acid oxidation.

  2000cited by this paper
• Body composition techniques and the four-compartment model in children.

  2000cited by this paper
• Abnormalities in branched-chain amino acid metabolism in cirrhosis: influence of hormonal and nutritional factors and directions for future research.

  1999cited by this paper
• The importance of the plasma amino acid molar ratio in patients with biliary atresia.

  1999cited by this paper
• Development of a minimally invasive protocol for the determination of phenylalanine and lysine kinetics in humans during the fed state.

  1998cited by this paper
• Defective nonoxidative leucine degradation and endogenous leucine flux in cirrhosis during an amino acid infusion

  1998cited by this paper
• Formation and Fate of Tyrosine

  1998cited by this paper
• Human hydrometry: comparison of multifrequency bioelectrical impedance with 2H2O and bromine dilution.

  1998cited by this paper
• Effect of long-term refeeding on protein metabolism in patients with cirrhosis of the liver

  1997cited by this paper
• L-[1-13C] phenylalanine oxidation as a measure of hepatocyte functional capacity in end-stage liver disease

  1997cited by this paper
• L-[1-(13)C] Phenylalanine oxidation as a measure of hepatocyte functional capacity in end-stage liver disease.

  1997cited by this paper
• Nutrient-induced thermogenesis and protein-sparing effect by rapid infusion of a branched chain-enriched amino acid solution to cirrhotic patients.

  1996cited by this paper
• Leucine metabolism in rats with cirrhosis.

  1996cited by this paper
• Growth hormone, insulinlike growth factor‐1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease

  1995cited by this paper
• Relative dilution spaces of 2H- and 18O-labeled water in humans.

  1994cited by this paper
• Long-term follow-up of growth in height after successful liver transplantation.

  1994cited by this paper
• Leucine and phenylalanine kinetics in compensated liver cirrhosis: effects of insulin.

  1993cited by this paper
• The nature of malnutrition in children with end-stage liver disease awaiting orthotopic liver transplantation.

  1992cited by this paper
• Nutritional support in children with end-stage liver disease: a randomized crossover trial of a branched-chain amino acid supplement.

  1992cited by this paper
• Body cell mass and leucine metabolism in cirrhosis.

  1992cited by this paper
• Bioelectrical impedance estimation of fat-free body mass in children and youth: a cross-validation study.

  1992cited by this paper
• In vivo differences between the turnover rates of leucine and leucine's ketoacid in stable cirrhosis.

  1992cited by this paper
• Measurements of total body and extracellular water in cirrhotic patients with and without ascites

  1991cited by this paper
• Branched-chain amino acid interactions with reference to amino acid requirements in adult men: valine metabolism at different leucine intakes.

  1991cited by this paper
• Branched-chain amino acid interactions with reference to amino acid requirements in adult men: leucine metabolism at different valine and isoleucine intakes.

  1991cited by this paper
• The design and validation of a diet for studies of amino acid metabolism in adult Humans.

  1990cited by this paper
• Skeletal muscle and whole-body protein turnover in cirrhosis.

  1990cited by this paper
• Phenylalanine flux, oxidation, and conversion to tyrosine in humans studied with L-[1-13C]phenylalanine.

  1990cited by this paper
• Plasma reciprocal pool specific activity predicts that of intracellular free leucine for protein synthesis.

  1989cited by this paper
• A Simple Nomogram for the Derivation of International Normalised Ratios for the Standardisation of Prothrombin Times

  1988cited by this paper
• Increased protein catabolism without hypermetabolism after human orthotopic liver transplantation.

  1987cited by this paper
• Clinical and statistical validity of conventional prognostic factors in predicting short‐term survival among cirrhotics

  1987cited by this paper
• Comparison of oral and intravenous administration of sodium bromide for extracellular water measurements.

  1987cited by this paper
• International Federation of Clinical Chemistry (IFCC) Scientific Committee, Analytical Section: approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 3. IFCC method for alanine aminotransferase (L-alanine: 2-oxoglutarate aminotransferase, EC 2

  1986cited by this paper
• Leucine metabolism in stable cirrhosis

  1986cited by this paper
• Statistical methods for assessing agreement between two methods of clinical measurement.

  1986cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985cited by this paper
• C-peptide measurement: methods and clinical utility.

  1984cited by this paper
• Tryptophan requirement of the 2.5-kg piglet determined by the oxidation of an indicator amino acid.

  1984cited by this paper
• Direct spectrophotometry of total bile acids in serum.

  1981cited by this paper
• Separation of bilirubin species in serum and bile by high-performance reversed-phase liquid chromatography.

  1981cited by this paper
• Total body water measurement in humans with 18O and 2H labeled water.

  1980cited by this paper
• Measurement of leucine metabolism in man from a primed, continuous infusion of L-[1-3C]leucine.

  1980cited by this paper
• Protein turnover in man measured with 15N: comparison of end products and dose regimes.

  1978cited by this paper
• Linear regression analysis

  1977cited by this paper
• Albumin determination by a modified bromcresol green method.

  1977cited by this paper
• Criteria for establishing a standardized method for determining alkaline phosphatase activity in human serum.

  1977cited by this paper
• Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty.

  1976cited by this paper
• Group experiments on the radioimmunological insulin determination.

  1974cited by this paper
• Determination of Body Composition of Children from Skinfold Measurements

  1971cited by this paper
• Body water, height, and weight during growth in normal children.

  1966cited by this paper
• AKUFO AND IBARAPA.

  1965cited by this paper

• Determining amino acid requirements in humans

  2024cites this paper
• Determination of a steady-state isotope dilution protocol for carbon oxidation studies in the domestic cat

  2023cites this paper
• Applying the indicator amino acid oxidation technique in the domestic cat: results of a pilot study and development of a non-steady state prediction model.

  2022cites this paper
• Amino acids, ammonia, and hepatic encephalopathy.

  2022cites this paper
• Malnutrition in Pediatric Chronic Cholestatic Disease: An Up-to-Date Overview

  2021cites this paper
• Nutritional Management of Children with Liver Disease

  2021cites this paper
• METABOLIC AND NUTRITIONAL REPERCUSSIONS OF LIVER DISEASE ON CHILDREN: HOW TO MINIMIZE THEM?

  2021cites this paper
• Liver Failure

  2021cites this paper
• Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases

  2021cites this paper
• Enteral Nutrition

  2021cites this paper
• Myopenia and Reduced Subcutaneous Adiposity in Children With Liver Disease are Associated With Adverse Outcomes.

  2020cites this paper
• Branched-chain amino acid supplementation for improving growth and development in term and preterm neonates.

  2020influential citation
• Evaluation and Management of Nutrition in Chronic Liver Disease

  2020cites this paper
• Malnutrition in Children With Chronic Disease.

  2019cites this paper
• Sarcopenia in Chronic Liver Disease: Impact on Outcomes

  2019cites this paper
• Persistence of Sarcopenia After Pediatric Liver Transplantation Is Associated With Poorer Growth and Recurrent Hospital Admissions

  2018cites this paper
• Effects of branched chain amino acid supplementation on patient care outcomes in adults and children with liver cirrhosis: A systematic review.

  2018cites this paper
• Characterization of a rat model of moderate liver dysfunction based on alpha-naphthylisothiocyanate-induced cholestasis.

  2017cites this paper
• Total Sulfur Amino Acid Requirements Are Not Altered in Children with Chronic Renal Insufficiency, but Minimum Methionine Needs Are Increased.

  2017cites this paper
• Recent developments in understanding protein needs - How much and what kind should we eat?

  2016cites this paper
• Nutritional Management of Children with Liver Disease

  2016cites this paper
• Cholestasis beyond the Neonatal and Infancy Periods

  2016cites this paper
• Branched-chain amino acid supplementation for improving nutrition in term and preterm neonates

  2016cites this paper
• Application of stable isotope tracers to examine phenylalanine metabolism and protein requirements in children with phenylketonuria (pku)

  2015cites this paper
• Enteral energy and macronutrients in end-stage liver disease.

  2014cites this paper
• Assessment of Growth and Development in Children With Hepatitis B Positivity

  2014influential citation
• EVALUATING DIETARY AMINO ACID ADEQUACY IN HORSES USING ISOTOPIC TECHNIQUES

  2014cites this paper
• Nutrition assessment and support in children with end-stage liver disease.

  2013cites this paper
• Bone health and Growth in Children post Liver Transplant

  2012cites this paper
• Nutritional support for liver disease.

  2012cites this paper
• Endocrine and bone metabolic complications in chronic liver disease and after liver transplantation in children.

  2012cites this paper
• Recent advances in determining protein and amino acid requirements in humans

  2012cites this paper
• Seaweed Digestibility and Methods used for Digestibility Determination

  2011cites this paper
• Tratamiento nutricio en la atresia de vías biliares

  2010cites this paper
• NUTRICIÓN ENTERAL EN HEPATOPATÍAS CRÓNICAS EN NIÑOS Y ADOLESCENTES

  2010cites this paper
• Protein and energy requirements for ‘optimal’ catch-up growth

  2010cites this paper
• Nutritional Considerations In Pediatric Liver Transplantation

  2009cites this paper
• Identification of urinary biomarkers useful for distinguishing a difference in mechanism of toxicity in rat model of cholestasis.

  2009cites this paper
• Nutritional status of children with chronic hepatitis B in a population with low socioeconomic status

  2009cites this paper
• Indicator amino acid oxidation is not affected by period of adaptation to a wide range of lysine intake in healthy young men.

  2009cites this paper
• Indicator amino acid oxidation: concept and application.

  2008cites this paper
• Recent advances in biliary atresia: prospects for novel therapies

  2008cites this paper
• Indicator Amino Acid Oxidation : Concept and Application 1 – 3

  2008cites this paper
• Assessment of protein nutritional status in children

  2008cites this paper
• Recent advances in biliary atresia: prospects for novel therapies.

  2008cites this paper
• Intestinal function in cholestasis and essential fatty acid deficiency

  2007cites this paper
• Nutrition for children with cholestatic liver disease.

  2007cites this paper
• Role of branched-chain amino acids in liver disease: the evidence for and against

  2007cites this paper
• Effect of Orthotopic Liver Transplantation (OLT) on Branched-Chain Amino Acid Requirement

  2006cites this paper
• Mild-to-moderate chronic cholestatic liver disease increases leucine oxidation in children.

  2006cites this paper
• Current World Literature

  2006cites this paper